|
Category: pharmaceuticals / chemical synthisis
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Physical Properties:
| Assay: | 95.00 to 100.00 %
|
| Food Chemicals Codex Listed: | No |
| Boiling Point: | 344.40 °C. @ 760.00 mm Hg (est)
|
| Vapor Pressure: | 0.000066 mmHg @ 25.00 °C. (est) |
| Flash Point: | 324.00 °F. TCC ( 162.10 °C. ) (est)
|
| logP (o/w): | 1.845 (est) |
| Soluble in: |
| | water, 1116 mg/L @ 25 °C (est) |
Organoleptic Properties:
| |
| Odor and/or flavor descriptions from others (if found). |
| |
| |
Cosmetic Information:
Suppliers:
Safety Information:
| Preferred SDS: View |
| |
| Hazards identification |
| |
| Classification of the substance or mixture |
| GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |
| None found. |
| GHS Label elements, including precautionary statements |
| |
| Pictogram | |
| |
| Hazard statement(s) |
| None found. |
| Precautionary statement(s) |
| None found. |
| Oral/Parenteral Toxicity: |
parenteral-frog LD50 363 mg/kg Archives Internationales de Pharmacodynamie et de Therapie. Vol. 289, Pg. 278, 1987.
intramuscular-mouse LD50 121 mg/kg Fortschritte der Medizin. Vol. 94, Pg. 793, 1976.
intraperitoneal-mouse LD50 34 mg/kg LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
BEHAVIORAL: TREMOR Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 10, Pg. 3141, 1982.
intravenous-mouse LD50 18 mg/kg LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
BEHAVIORAL: TREMOR Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 10, Pg. 3141, 1982.
oral-mouse LD50 223 mg/kg LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
BEHAVIORAL: TREMOR Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 10, Pg. 3141, 1982.
intraperitoneal-rat LD50 42 mg/kg BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
BEHAVIORAL: TREMOR
LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 10, Pg. 3141, 1982.
intravenous-rat LD50 26 mg/kg BEHAVIORAL: TREMOR
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 10, Pg. 3141, 1982.
oral-rat LD50 180 mg/kg Archives of Toxicology. Vol. 54, Pg. 275, 1983.
|
| Dermal Toxicity: |
subcutaneous-mouse LD50 52 mg/kg BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES
BEHAVIORAL: TREMOR Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 10, Pg. 3141, 1982.
subcutaneous-rat LD50 80 mg/kg BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES
BEHAVIORAL: TREMOR Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 10, Pg. 3141, 1982.
|
| Inhalation Toxicity: |
|
Not determined
|
Safety in Use Information:
| Category: | pharmaceuticals / chemical synthisis |
| Recommendation for levamisole hydrochloride usage levels up to: | | | not for fragrance use.
|
| |
| Recommendation for levamisole hydrochloride flavor usage levels up to: |
| | not for flavor use.
|
Safety References:
References:
| | (6S)-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole;hydrochloride |
| NIST Chemistry WebBook: | Search Inchi |
| Canada Domestic Sub. List: | 16595-80-5 |
| Pubchem (cid): | 27944 |
| Pubchem (sid): | 134991423 |
Other Information:
Potential Blenders and core components note
Potential Uses:
Occurrence (nature, food, other): note
Synonyms:
| | imidazo(2,1-b)thiazole, 2,3,5,6-tetrahydro-6-phenyl-, monohydrochloride, (-)- (8CI) | | | imidazo(2,1-b)thiazole, 2,3,5,6-tetrahydro-6-phenyl-, monohydrochloride, (S)- | | | imidazo(2,1-b)thiazole, 2,3,5,6-tetrahydro-6-phenyl-, monohydrochloride, L-(-)- | | | imidazo[2,1-b]thiazole, 2,3,5,6-tetrahydro-6-phenyl-, (6S)-, hydrochloride (1:1) | | | lecamisole HCl | | | levamisol hydrochloride | | | levomysol hydrochloride | | | nilverm | | | niratic hydrochloride | | | niratic-puron hydrochloride | | (6S)-6- | phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole hydrochloride | | (6S)-6- | phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole hydrochloride (1:1) | | 6- | phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole hydrochloride (1:1) | | (6S)-6- | phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole;hydrochloride | | (6S)-6- | phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazolhydrochlorid | | (S)-(-)-6- | phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole hydrochloride | | (S)-6- | phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole hydrochloride | | L-(-)-2,3,5,6- | tetrahydro-6-phenyl-imidazo(2,1-b)thiazole hydrochloride | | (-)-2,3,5,6- | tetrahydro-6-phenylimidazo[2,1-b]thiazole hydrochloride | | (-)-2,3,5,6- | tetrahydro-6-phenylimidazo[2,1-b]thiazole monohydrochloride | | L-(-)-2,3,5,6- | tetrahydro-6-phenylimidazo[2,1-b]thiazole Monohydrochloride | | | tetramisole hydrochloride | | (-)- | tetramisole hydrochloride | | L- | tetramisole hydrochloride |
Articles:
|